Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol

Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol

Achieving adequate immunosuppression for lung transplant recipients in the first year after lung transplantation is a key challenge. Prophylaxis of allograft rejection must be balanced with the adverse events associated with immunosuppressive drugs, for example infection, renal failure, and diabetes...

Full description

Bibliographic Details
Main Authors: Macé M. Schuurmans, Miro E. Raeber, Maurice Roeder, René Hage
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medicina
Subjects:
lung transplantation
immunosuppression
therapeutic drug monitoring
lymphocytes
eosinophils
Online Access:https://www.mdpi.com/1648-9144/59/3/488

Internet

https://www.mdpi.com/1648-9144/59/3/488

Similar Items